Cash Flow Statement
Growth Metrics

Biolife Solutions (BLFS) Capital Expenditures (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Capital Expenditures for 16 consecutive years, with $4.3 million as the latest value for Q4 2025.

  • Quarterly Capital Expenditures rose 42480.0% to $4.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.5 million through Dec 2025, up 8757.94% year-over-year, with the annual reading at $9.5 million for FY2025, 8757.94% up from the prior year.
  • Capital Expenditures for Q4 2025 was $4.3 million at Biolife Solutions, down from $5.1 million in the prior quarter.
  • The five-year high for Capital Expenditures was $6.8 million in Q3 2021, with the low at -$2.5 million in Q2 2023.
  • Average Capital Expenditures over 5 years is $1.2 million, with a median of $1.0 million recorded in 2022.
  • The sharpest move saw Capital Expenditures tumbled 7578.26% in 2021, then soared 42480.0% in 2025.
  • Over 5 years, Capital Expenditures stood at $1.6 million in 2021, then crashed by 175.54% to -$1.2 million in 2022, then soared by 295.86% to $2.3 million in 2023, then plummeted by 99.57% to $10000.0 in 2024, then skyrocketed by 42480.0% to $4.3 million in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $4.3 million, $5.1 million, and -$462000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.